查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
遥测心电图设备全球市场-2022-2029
市场调查报告书
商品编码
1140676

遥测心电图设备全球市场-2022-2029

Global ECG Telemetry Devices Market - 2022-2029
出版日期: | 出版商: DataM Intelligence | 英文 180 Pages | 商品交期: 约2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

市场动态

家庭监控设备将引领市场增长。

对家庭护理监测设备的需求将会增加，从而减少医院进行心臟检查的成本和时间。对于心血管疾病等危及生命的疾病，定期心臟检查很重要，而家庭护理监测设备则更容易。因此，这些设备有助于遥测心电图设备市场的增长。

此外，心血管疾病发病率和患病率的增加正在推动市场增长。在过去的二十年里，高收入国家的心血管和其他心臟病死亡人数有所下降，但在低收入和中等收入国家却以惊人的速度增加。据世界卫生组织称，大约 80.0% 的心血管疾病死亡发生在非洲、拉丁美洲和亚太地区等低收入和中等收入地区。在北美，心肌梗死死亡率受多种因素驱动，包括药物洗脱支架、经皮冠状动脉成形术的增加以及主要不良心血管疾病一级和二级预防的循证药物持续下降。

按地区划分的流行率。

北美将是预测期内的主要地区。

在预测期内，北美市场将以最大的份额引领全球遥测心电设备市场。心血管疾病是美国的主要死亡原因，也是急症护理住院日和就诊的主要原因。根据美国疾病控制和预防中心 (CDC) 的数据，心血管疾病在美国每年造成约 610,000 人死亡，占死亡人数的近四分之一。因此，美国对心电遥测设备的需求相当准确，这推动了该地区尤其是美国的市场增长。

此外，预计亚太地区在预测期内将以全球最高的复合年增长率增长。这一增长归因于政府在医院、计算机化和基础设施方面的举措增加。亚太地区现有的医疗保健基础设施仍在开发中，包括印度、中国、日本和澳大利亚。发展中地区开发新型遥测心电图设备的潜力巨大。全球约一半的心血管疾病负担由亚太地区承担。因此，大量患者表明遥测心电图设备市场的迫切需求。

竞争格局。

心电图遥测设备市场由少数公司主导。 Aerotel Medical Systems Ltd.、BioTelemetry Inc.、GE Healthcare、Medtronic Plc、iRhythm Technologies Inc.、Nihon Kohden、Philips Healthcare 和 Medicalgorithmics SA 等公司是市场增长的关键参与者。主要参与者正在执行多项增长战略，例如产品发布、收购和合作伙伴关係，据估计这些战略将推动全球遥测心电图设备市场。 2022 年 3 月，GE Healthcare 宣布与 HIMSS 的 AliveCor 建立合作伙伴关係，以推出一个新的数字平台。我们将在奥兰多全球健康会议暨展览会上发布两项重大公告。第一个公告是关于开发利用人工智能的数位健康平台。另一项宣布是与总部位于加利福尼亚州山景城的 AliveCor 建立合作伙伴关係，这将允许从医疗设备製造商的心电图仪中获取的心电图直接进入 GE Healthcare 的 MUSE 心臟管理系统。 2022 年 4 月，GE Healthcare 和美敦力宣布合作，以满足日益增长的门诊护理需求。该合作伙伴关係为客户提供了广泛的产品组合、金融解决方案和卓越的服务。

COVID-19 的影响。它将对遥测心电图设备的全球市场产生负面影响。

随着 COVID-19 大流行席捲全球多个地区，在全球遥测心电图设备市场运营的公司拥有良好的前景。预计这些供应商将加快生产步伐，以满足对遥测心电图设备不断增长的需求。最近，对用于监测 COVID-19 的新技术的投资有所增加。这为在全球遥测 ECG 设备市场上运营的公司提供了广阔的发展空间。此外，遥测心电图设备市场的主要参与者正专注于开发定制设备，用于对 COVID-19 患者进行基本监测。

内容

第 1 章研究方法与范围

  • 调查方法
  • 调查目的和范围

第 2 章市场定义和概述

第 3 章执行摘要

  • 按产品划分的市场细分
  • 按应用划分的市场细分
  • 按地区划分的市场细分

第 4 章市场动态

  • 市场影响因素
  • 促进因素
    • 心血管疾病高发
    • 新兴国家的医疗保健支出增加
    • 远程监控技术的技术进步
  • 抑制因素
    • 复杂的报销政策
  • 商机
  • 影响分析

第 5 章行业分析

  • 波特五力分析
  • 供应链分析
  • 价值链分析
  • PEST 分析
  • 定价分析
  • 监管分析
  • 保险报销分析
  • 未满足的需求
  • 专利趋势

第 6 章 COVID-19 分析

  • COVID-19 的市场分析
    • COVID-19 之前的市场情景
    • COVID-19 的当前市场情景
    • COVID-19 后或未来情景
  • COVID-19 期间的价格动态
  • 供需范围
  • 大流行期间与市场相关的政府举措
  • 製造商的战略举措
  • 总结

第 7 章按产品分类

  • 事件监测、MCT（移动心臟遥测）
  • 其他

第 8 章按应用程序

  • 心律失常
  • 心肌缺血/心肌梗塞
  • 起搏器监测
  • 其他

第 9 章按地区

  • 北美
    • 美国
    • 加拿大
    • 墨西哥
  • 欧洲
    • 德国
    • 英国
    • 法国
    • 意大利
    • 西班牙
    • 其他欧洲
  • 南美洲
    • 巴西
    • 阿根廷
    • 其他南美洲
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 澳大利亚
    • 其他亚太地区
  • 中东和非洲

第 10 章竞争格局

  • 竞争场景
  • 市场定位/市场份额分析
  • 併购分析

第 11 章公司简介

  • Aerotel Medical Systems Ltd.
    • 公司概况
    • 产品组合和描述
    • 主要亮点
    • 财务摘要
  • BioTelemetry Inc.
  • GE Healthcare
  • Medtronic Plc
  • iRhythm Technologies Inc.
  • Nihon Kohden Corporation
  • Philips Healthcare
  • Medicalgorithmics SA
  • Preventice Solutions Inc.
  • Hill-Rom Services Inc.（Welch Allyn）
  • Other Companies

第 12 章数据M

简介目录
Product Code: DMHCIT3000

Market Overview

ECG telemetry devices market was valued at USD XX million in 2021. It is forecasted to reach USD XX million by 2029, growing at a CAGR of 8 % during the forecast period (2022-2029).

ECG device monitors and records the electrical movement of the heart. It detects and gathers electrical impulses generated by the polarization and depolarization of cardiac tissue and translates them into a waveform. It helps physicians or cardiologists diagnose cardiac abnormalities and the size and position of chambers. This technique detects cardiac abnormalities and analyzes the effects of drugs or devices used to regulate the heart. The ECG telemetry device can detect complex dysrhythmias and myocardial ischemia. The ECG telemetry devices market is driving due to the growing government interventions to reform the healthcare sector. Moreover, technological advances and increasing government interventions to render quality medical devices at affordable prices for miniature and telemetry devices have grown significantly in the past couple of years.

Market Dynamics: Home monitoring devices lead the market's growth.

Homecare monitoring devices' demand increases, reducing the cost and time taken in hospitals for heart checkups. For life-threatening diseases, such as cardiovascular disorders, regular checkup of the heart is crucial, and it is made easy by homecare monitoring devices. Hence, these devices are helping the ECG telemetry devices market to grow.

Also, the Increasing incidence and prevalence of cardiovascular diseases drive market growth. Over the past two decades, fatalities due to cardiovascular disease and other heart diseases have been declining in high-income countries; however, they have been rising at an alarming rate in lower and middle-income countries. Around 80.0% of the mortalities caused due to CVD occur in low-middle income group regions, such as Africa, Latin America, and Asia-Pacific, as per the WHO. In North America, myocardial infarction fatality is continuously decreasing due to several factors, such as drug-eluting stents, increasing adoption of percutaneous coronary angioplasty, and evidence-based medications for primary and secondary prevention of major adverse cardiovascular diseases.

Market Segmentation: Event monitoring and MCT (Mobile Cardiac Telemetry) segment accounted for the highest share in global ECG telemetry devices market.

The event monitoring and MCT (Mobile Cardiac Telemetry) segment are anticipated to dominate the market with the largest value share. Mobile cardiac telemetry is the most modern of the monitoring options. MCT devices are small portable monitors that automatically send data when a cardiac anomaly is detected. It is superior to other forms of ambulatory cardiac monitoring (Holter or Event Monitoring); therefore, its demand is expected to rise in the ECG telemetry device market during the forecast period.

By application, the ECG telemetry devices market is classified into arrhythmia, myocardial ischemia and infarction, pacemaker monitoring, and others. In terms of application, the arrhythmia segment is expected to dominate the global ECG telemetry devices market during the forecast period. In arrhythmia, the heart rhythm functions abnormally, wherein the electrical impulses either occur too fast or too slow, leading to the reduced proficiency of the heart to pump blood. There are various devices used in arrhythmias diagnosis. The ECG telemetry devices are one of the most efficient tools to detect arrhythmias. According to a World Health organization estimation data, the aged population above 60 years and over increased in 2020. By 2050, the aged population above 60 years and older will double (2.1 billion). The number of persons aged 80 years or older is expected to triple between 2020 and 2050 to reach 426 million. As this population is more prone to cardiovascular diseases such as arrhythmias, the demand for ECG telemetry devices to diagnose arrhythmia is expected to impact the market positively.

Geographical Penetration: North America is the dominating region during the forecast period.

During the forecast period, the North American market leads with the largest share in the global ECG telemetry devices market. Cardiovascular diseases are the primary cause of mortality in the U.S. and the major cause of acute hospital bed days and physician visits. According to the Centers for Disease Control and Prevention (CDC), about 610,000 mortalities are registered due to cardiovascular diseases in the U.S. every year, which accounts for almost one in every four fatalities. Therefore, the demand for ECG telemetry devices is considerably accurately high in the U.S., which drives the market growth in the region, especially in the U.S.

Moreover, the Asia Pacific region is expected to grow at the highest CAGR globally during the forecast period. This growth is due to the increased government initiatives on hospitals, computerization, and infrastructure. The existing healthcare infrastructure in the Asia-Pacific countries such as India, China, Japan, and Australia is still in progress. Significant prospects exist for developing novel ECG telemetric devices in developing regions. Approximately half of the burden of the world of CVD is carried by the Asia-Pacific region. Therefore, the large patient population indicates an imminent need for the ECG telemetry device market.

Competitive Landscape:

The ECG telemetry devices market is dominated by a few companies. Key players in the market's growth include Aerotel Medical Systems Ltd., BioTelemetry Inc., GE Healthcare, Medtronic Plc, iRhythm Technologies Inc., Nihon Kohden Corporation, Philips Healthcare, and Medicalgorithmics SA, among others. The key players execute several growth strategies, such as product launches, acquisitions, and collaborations, which are estimated to boost the global ECG telemetry devices market. In March 2022, GE Healthcare announced a partnership with AliveCor to launch a new digital platform at HIMSS. The company made two major announcements at the Orlando Global Health Conference & Exhibition. The company's first announcement is the development of an AI-enabled digital health platform. And another announcement is about a partnership with Mountain View, California-based AliveCor, through which electrocardiogram readings taken on the medical device company's EKG device will be delivered directly into GE Healthcare's MUSE Cardiac Management System. In April 2022, GE Healthcare and Medtronic Announced a Collaboration to Meet the Growing Need for Outpatient Care. Under this collaboration, customers accessed extensive product portfolios, financial solutions, and exceptional service.

COVID-19 Impact: Negative impact on the global ECG Telemetry Devices market.

The companies operating in the global ECG telemetry devices market have a good prospect at their disposal as the COVID-19 pandemic grips several parts worldwide. These vendors are expected to accelerate their manufacturing pace to meet the expanding demand for ECG telemetry devices. Investments in novel technologies used to monitor COVID-19 have increased in recent times. It has offered a large playfield of advancement for the companies operating in the global ECG telemetry devices market. Furthermore, the ECG telemetry devices market's leading players focus on developing custom-made devices to monitor the fundamentals of COVID-19 patients.

Table of Contents

1. Methodology and Scope

  • 1.1. Research Methodology
  • 1.2. Research Objective and Scope of the Report

2. Market Definition and Overview

3. Executive Summary

  • 3.1. Market Snippet by Product
  • 3.2. Market Snippet by Application
  • 3.3. Market Snippet by Region

4. Market Dynamics

  • 4.1. Market Impacting Factors
  • 4.2. Drivers
    • 4.2.1. The high incidence rate of cardiovascular diseases
    • 4.2.2. Improved spending on healthcare in emerging markets
    • 4.2.3. Technological Advancements in Remote Monitoring Technologies
  • 4.3. Restraints:
    • 4.3.1. Complex Reimbursement Policies
  • 4.4. Opportunity
  • 4.5. Impact Analysis

5. Industry Analysis

  • 5.1. Porter's Five Forces Analysis
  • 5.2. Supply Chain Analysis
  • 5.3. Value Chain Analysis
  • 5.4. PEST Analysis
  • 5.5. Pricing Analysis
  • 5.6. Regulatory Analysis
  • 5.7. Reimbursement Analysis
  • 5.8. Unmet Needs
  • 5.9. Patent Trends

6. COVID-19 Analysis

  • 6.1. Analysis of Covid-19 on the Market
    • 6.1.1. Before COVID-19 Market Scenario
    • 6.1.2. Present COVID-19 Market Scenario
    • 6.1.3. After COVID-19 or Future Scenario
  • 6.2. Pricing Dynamics Amid Covid-19
  • 6.3. Demand-Supply Spectrum
  • 6.4. Government Initiatives Related to the Market During Pandemic
  • 6.5. Manufacturers Strategic Initiatives
  • 6.6. Conclusion

7. By Product

  • 7.1. Introduction
  • 7.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment
  • 7.3. Market Attractiveness Index, By Product Segment
    • 7.3.1. Event Monitoring and MCT (Mobile Cardiac Telemetry)
      • 7.3.1.1. Introduction
      • 7.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 7.3.2. Others

8. By Application

  • 8.1. Introduction
  • 8.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application Segment
  • 8.3. Market Attractiveness Index, By Application Segment
    • 8.3.1. Arrhythmias*
      • 8.3.1.1. Introduction
      • 8.3.1.2. Market Size Analysis, and Y-o-Y Growth Analysis (%)
    • 8.3.2. Myocardial Ischemia and Infarction
    • 8.3.3. Pacemaker Monitoring
    • 8.3.4. Others

9. By Region

  • 9.1. Introduction
  • 9.2. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region
  • 9.3. Market Attractiveness Index, By Region
  • 9.4. North America
    • 9.4.1. Introduction
    • 9.4.2. Key Region-Specific Dynamics
    • 9.4.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.4.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.4.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.4.5.1. The U.S.
      • 9.4.5.2. Canada
      • 9.4.5.3. Mexico
  • 9.5. Europe
    • 9.5.1. Introduction
    • 9.5.2. Key Region-Specific Dynamics
    • 9.5.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.5.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.5.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.5.5.1. Germany
      • 9.5.5.2. The U.K.
      • 9.5.5.3. France
      • 9.5.5.4. Italy
      • 9.5.5.5. Spain
      • 9.5.5.6. Rest of Europe
  • 9.6. South America
    • 9.6.1. Introduction
    • 9.6.2. Key Region-Specific Dynamics
    • 9.6.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.6.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.6.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.6.5.1. Brazil
      • 9.6.5.2. Argentina
      • 9.6.5.3. Rest of South America
  • 9.7. Asia Pacific
    • 9.7.1. Introduction
    • 9.7.2. Key Region-Specific Dynamics
    • 9.7.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.7.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.7.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country
      • 9.7.5.1. China
      • 9.7.5.2. India
      • 9.7.5.3. Japan
      • 9.7.5.4. Australia
      • 9.7.5.5. Rest of Asia Pacific
  • 9.8. The Middle East and Africa
    • 9.8.1. Introduction
    • 9.8.2. Key Region-Specific Dynamics
    • 9.8.3. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product
    • 9.8.4. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Application
    • 9.8.5. Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

10. Competitive Landscape

  • 10.1. Competitive Scenario
  • 10.2. Market Positioning/Share Analysis
  • 10.3. Mergers and Acquisitions Analysis

11. Company Profiles

  • 11.1. Aerotel Medical Systems Ltd.*
    • 11.1.1. Company Overview
    • 11.1.2. Product Portfolio and Description
    • 11.1.3. Key Highlights
    • 11.1.4. Financial Overview
  • 11.2. BioTelemetry Inc.
  • 11.3. GE Healthcare
  • 11.4. Medtronic Plc
  • 11.5. iRhythm Technologies Inc.
  • 11.6. Nihon Kohden Corporation
  • 11.7. Philips Healthcare
  • 11.8. Medicalgorithmics SA
  • 11.9. Preventice Solutions Inc.
  • 11.10. Hill-Rom Services Inc. (Welch Allyn)
  • 11.11. Other Companies

12. DataM Intelligence

  • 12.1. Appendix
  • 12.2. About Us and Services
  • 12.3. Contact Us